Clinical trials
Phase 3 Hepatitis C trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
247 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 11 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 8 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 20 |
| 2012 | 29 |
| 2013 | 23 |
| 2014 | 30 |
| 2015 | 32 |
| 2016 | 22 |
| 2017 | 18 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 206 |
| Unknown status | 17 |
| Terminated | 16 |
| Withdrawn | 7 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 40 |
| Gilead Sciences | 35 |
| Bristol-Myers Squibb | 26 |
| Merck Sharp & Dohme LLC | 10 |
| Janssen R&D Ireland | 7 |
| AbbVie (prior sponsor, Abbott) | 6 |
| Boehringer Ingelheim | 4 |
| Debiopharm International SA | 4 |
| French National Agency for Research on AIDS and Viral Hepatitis | 4 |
| GlaxoSmithKline | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 247 |
| Hepatitis C, Chronic | 82 |
| Fibrosis | 25 |
| Hepatitis | 13 |
| Liver Diseases | 12 |
| Virus Diseases | 11 |
| Liver Cirrhosis | 10 |
| HIV Infections | 9 |
| Acquired Immunodeficiency Syndrome | 8 |
| Hepatitis, Chronic | 6 |
Trials
Showing 1 to 25 of 247. Each trial links to its page on Pharma Observatory.
147 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.